Amin-Hanjani Sepideh, Charbel Fady T
Department of Neurosurgery, University of Illinois at Chicago, Neuropsychiatric Institute (MC 799), 912 South Wood Street, Chicago, IL 60612, USA.
Neurol Clin. 2006 Nov;24(4):729-43. doi: 10.1016/j.ncl.2006.06.010.
The role of surgical revascularization for patients who have ischemic disease remains controversial. Despite the previous EC-IC bypass trial that failed to demonstrate the benefit from STA-MCA bypass compared with medical therapy, however, there is mounting evidence that the procedure should be considered in selected patients. Bypass remains a mainstay of treatment in moyamoya disease and in flow replacement in the setting of planned vessel sacrifice.
对于患有缺血性疾病的患者，外科血管重建术的作用仍存在争议。尽管之前的颅外-颅内搭桥试验未能证明与药物治疗相比，颞浅动脉-大脑中动脉搭桥术有何益处，然而，越来越多的证据表明，在特定患者中应考虑该手术。搭桥术仍然是烟雾病治疗的主要手段，也是在计划牺牲血管的情况下进行血流置换的主要方法。
